Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Cash & Current Investments of $33.3 million for Q2 2026, up 43.62% year-over-year from $23.2 million in Q2 2025, and down 16.05% quarter-over-quarter from $39.7 million in Q1 2026.
Jushi Holdings (JUSHF) Cash & Current Investments (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Cash & Current Investments for 6 consecutive years, with $33.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Current Investments rose 43.62% year-over-year to $33.3 million; the TTM figure through Jun 2026 stood at $33.3 million (up 43.62% YoY), while the FY2025 annual figure was $24.0 million, up 23.19% from the prior year.
- Cash & Current Investments declined to $33.3 million in Q2 2026 per JUSHF's latest filing, from $39.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $43.2 million in Q2 2022 and bottomed at $18.5 million in Q1 2023.
- Historically, Cash & Current Investments has averaged $28.1 million across 5 years, with a median of $28.3 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 72.41% — and 2024, when it surged 53.81%.
- Jushi Holdings' Cash & Current Investments stood at $26.2 million in 2022, then climbed by 11.3% to $29.2 million in 2023, then slumped by 33.04% to $19.5 million in 2024, then increased by 23.19% to $24.0 million in 2025, then soared by 38.6% to $33.3 million in 2026.
- Business Quant data shows JUSHF's Cash & Current Investments at $33.3 million in Q2 2026, $39.7 million in Q1 2026, and $24.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 164.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 33.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.33 Mn |
| Mar 31, 2026 | 39.70 Mn |
| Dec 31, 2025 | 24.05 Mn |
| Sep 30, 2025 | 23.17 Mn |
| Jun 30, 2025 | 23.21 Mn |
| Mar 31, 2025 | 25.96 Mn |
| Dec 31, 2024 | 19.52 Mn |
| Sep 30, 2024 | 20.74 Mn |
| Jun 30, 2024 | 32.88 Mn |
| Mar 31, 2024 | 28.41 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.32 Mn |
| Jun 30, 2023 | 29.91 Mn |
| Mar 31, 2023 | 18.47 Mn |
| Dec 31, 2022 | 26.20 Mn |
| Sep 30, 2022 | 31.06 Mn |
| Jun 30, 2022 | 43.19 Mn |
| Dec 31, 2021 | 94.96 Mn |